Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 943-665-0 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
- Endpoint:
- basic toxicokinetics in vitro / ex vivo
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- other:
Reference
Description of key information
Toxicokinetic Assessment
No specific study was performed on the absorption/distribution/metabolism/excretion (ADME) of RD 14153 but data are currently available from the physico-chemical andin vivotoxicology studies.
Absorption
Oral route
The physico-chemical characteristics of RD 14153 suggest that the UVCB may be well absorbed via the gastro-intestinal tract. The molecular weight is a broad range since RD 14153 is a UVCB (MW 172.23 – 625.04), but the reported Log P value is low (Log P = 1.02) and its solubility in water is medium to low at 0.321 g/L (average) at 20°C. These values do not suggest low oral absorption. A pKa (dissociation constant) in water has not been determined.
The low toxicity in the acute oral toxicity study and the oral 14-day repeat-dose dose toxicity study does not necessarily support low bioavailability; rather it may be a function of innate low toxicity associated with the structural and functional characteristics of the molecules in the UVCB.
Dermal route
RD 14153 is a solid with a broad MW range and a Log P value of 1.02. Its solubility in water is medium to low at 0.321 g/L(average) at 20°C. A solid substance with medium to low water solubility and a Log P value of below 6.0 must be considered capable of significant systemic absorption though the dermal route. The substance must be sufficiently soluble in water to partition from the stratum corneum into the epidermis. Water solubility above 100 mg/L, absorption is anticipated to be moderate to high and therefore RD 14153 would be anticipated to be significant.RD 14153 is not classified as askin sensitiser based onin vivodata, but this does not suggest poor absorption since it may lack toxicological activity.
Inhalation route
With a vapour pressure at 13 Pa at 25°C and boiling temperature not determined because the freezing temperature is so high, RD 14153 is not a highly volatile substance and therefore significant exposure as a vapour is not likely, however no inhalation study is available to investigate toxicity of particles via the inhalation route. RD 14153 has a mean particle size of5.9 ± 1.4 µmwhich suggests that a significant proportion of the RD 14153 particles will be respirable into the lung. Once particles are in the lung, absorption can be assumed to be 100%.
Distribution
The low toxicity findings from the oral acute and repeated dose studies provide no evidence for or against systemic distribution. In the absence of other information it is not possible to make conclusions on the distribution of RD 14153 in the body.
Metabolism
No data are available on metabolism in the existing toxicity studies. There was no evidence of any effect on tissues with high metabolism capability which could have provided evidence for metabolism.
Excretion
No data are available on metabolism or excretion in the existing toxicity studies. There are no otherin vivodata on the way in which RD 14153 is excreted.
Molecular weight of RD14153 is a range. Small organic compounds are more likely to be excreted in the urine, particularly those that are water soluble. Biliary excretion is more likely for high molecular weight compounds either because of biotransformation by phase 2 conjugation or because the parent is innately large (>500 MW). Therefore it is possible that the smaller molecules in RD 14153 may be excreted via the urine and the larger molecules may be excreted via biliary excretion. However, there is no evidence for or against this and it will depend on the extent of metabolism.
Conclusion
There is no strong experimental evidence from toxicity studies for the oral absorption of RD 14153 because the toxicity is so low. However, the physicochemical properties of RD14153 including relatively low water solubility, low LogP and a relatively large molecular weight range suggest that absorption via the oral and dermal routes cannot be ruled out and may be significant. Exposure via the lung to particulate RD 14153 is likely to result in significant absorption because of the small particle size and in the absence of further information should be assumed to be 100%. However, the vapour pressure of RD 14153 is relatively low and inhalation exposure to RD 14153 vapour is not considered to be high. There is no evidence of distribution metabolism, metabolic fate or excretion. Excretion via the kidney is considered a possibility based on the low LogP and low molecular weight for some constituents of the UVCB. Excretion via the biliary route particularly for larger molecular weight constituents of RD 14153 may be possible too. There was no information on bioaccumulation but based on the low LogP significant bioaccumulation is not anticipated.
Key value for chemical safety assessment
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.